In 2014, a local news program reported that a person with ALS named Mike McDuff had experienced dramatic improvements in their speech, swallowing and limb strength while taking a supplement regimen containing lunasin.
Dr. Richard Bedlack of the Duke ALS Clinic decided to perform a clinical trial. Fifty people with ALS were put on the exact Lunasin containing regimen that Mike McDuff had taken and were followed for a year. The trial finished in September 2017.
Unfortunately, there was no evidence that Lunasin slowed, stopped or reversed ALS in any of the trial participants. Dr. Bedlack concluded that Lunasin was not a useful treatment for ALS and that Mike McDuff likely had some other explanation for his ALS reversal such as an ALS mimic syndrome or a genetic resistance to the disease.
Keyword: lunasin als